Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
iN Therapeutics logo — 의학 및 약학 연구개발업

iN Therapeutics

의학 및 약학 연구개발업

Founded 2020 Korea South Korea South 8 employees Series B Total: $40.00B Biotechnology, Health and Wellness +1

General Information

Company Name iN Therapeutics
Founded Year 2020
Location Korea South Korea South +1
Employees 8
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series B
Social

Get notified when iN Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About iN Therapeutics

is a biotech startup based in Korea South, established in 2020. It is a spin-off from the renowned pharmaceutical company, Daewoong Pharmaceuticals, and focuses on medical and pharmaceutical research and development. The company has developed a cutting-edge drug discovery platform for ion channel, Nav1.7 non-opioid analgesic, as well as treatments for hearing loss and neurological diseases. With a decade of experience, iN Therapeutics possesses the world’s premier ion channel evaluation platform and development knowledge, making it a promising player in targeting various CNS (Central Nervous System) diseases. Recently, iN Therapeutics secured a significant KRW26.00B Series B investment on 07 February 2022 from a noteworthy group of investors including Aju IB Investment, DAYLI Partners, E&Investment, InterVest, STIC, Timefolio Asset Management, Shinhan Capital, Kiwoom Investment, and Yuanta Investment. This injection of funds is a testament to the company’s potential and the confidence investors have in its innovative approach to drug development and disease treatment. Overall, iN Therapeutics’ strong industry connections, innovative approach, and strategic partnerships position it as a promising player in the biotechnology and pharmaceutical sectors, with potential for significant growth and impact in the medical field.

Taxonomy: Biotech, Pharmaceuticals, Drug discovery, Ion channel, Non-opioid analgesic, Hearing loss, Neurological diseases, CNS diseases, Biomedical research, Medical technology, Therapeutics, Research and development, Spin-off, New drug development, Biopharmaceuticals

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 9
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		07 Feb 2022
Series A •••••• 1
Investor
25 Feb 2021

iN Therapeutics Alternatives & Competitors

iN Therapeutics vs
Autifony Therapeutics
Autifony Therapeutics

Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders

Series Unknown
37 employees
Biotechnology, Health and Wellness
iN Therapeutics vs
Leadopharma
Leadopharma

Pioneering the future of pain, epilepsy, depression, and neurodegenerative treatment through innovat...

Series A
Biotechnology, Pharmaceutical
iN Therapeutics vs
NMD Pharma A/S
NMD Pharma A/S Denmark

A clinical-stage biotech company focused on developing life-changing therapies for neuromuscular dis...

Series B
61 employees
Health and Wellness, Pharmaceutical

FAQ About iN Therapeutics

의학 및 약학 연구개발업
iN Therapeutics was founded in 2020.
iN Therapeutics is headquartered in Korea South.
iN Therapeutics operates in the following industries: Biotechnology, Health and Wellness, Pharmaceutical.
iN Therapeutics has approximately 8 employees.
iN Therapeutics has completed 2 funding rounds, raising a total of $40.00B. The latest funding stage is Series B.
Top alternatives and competitors to iN Therapeutics include Autifony Therapeutics, Leadopharma, NMD Pharma A/S, PYC Therapeutics (ASX: PYC), INVENT Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iN Therapeutics and Autifony Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors iN Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy